The hemodynamic interactions of combination therapy with α-blockers and phosphodiesterase-5 inhibitors compared to monotherapy with α-blockers: a systematic review and meta-analysis
Sign Up to like & getrecommendations! Published in 2020 at "International Urology and Nephrology"
DOI: 10.1007/s11255-020-02454-6
Abstract: Objective The present study systematically reviewed the safety of combined treatment with an alpha blocker and phosphodiesterase-5 inhibitor. Materials and methods The study was performed according to the PRISMA statement. The included studies were randomized… read more here.
Keywords: combined treatment; alpha blocker; monotherapy; meta analysis ... See more keywords
Alpha Blocker and 5-Alpha Reductase Inhibitor Prescribing Habits among Urologists and Primary Care Physicians
Sign Up to like & getrecommendations! Published in 2019 at "Urology Practice"
DOI: 10.1097/upj.0000000000000001
Abstract: AbstractIntroduction:While primary care physicians often prescribe medical therapy for voiding symptoms attributed to benign prostate enlargement, it is not clear to what extent they use novel or v... read more here.
Keywords: alpha blocker; care physicians; primary care; alpha reductase ... See more keywords
Predictive factors for alpha blocker use after transurethral prostatectomy: Can preoperative urodynamic outcome predict alpha blocker medication after surgery?
Sign Up to like & getrecommendations! Published in 2022 at "PLoS ONE"
DOI: 10.1371/journal.pone.0274399
Abstract: Objective To analyze the diagnostic value of conducting urodynamic study (UDS) and show predictors for alpha blocker use 12 months after transurethral prostatectomy. Materials and methods Our study includes 406 participants that had a transurethral… read more here.
Keywords: surgery; blocker use; transurethral prostatectomy; blocker ... See more keywords